Congresswoman Diana Harshbarger, 17 Colleagues Introduce Bill to Prohibit Federal Government Rationing of COVID-19 Antibody Treatments

Press Release

Today, U.S. Representative Diana Harshbarger (TN-01) and 17 of her fellow representatives introduced the Treatment Restoration for Emergency Antibody Therapeutics (TREAT) Act.

This legislation will overturn President Biden's recent Department of Health and Human Services (HHS) policy that restricts hospitals and other health facilities from ordering monoclonal antibody (mAb) treatments to treat COVID-19 symptoms directly from manufacturers to meet local demand.

"It's completely unacceptable that the Biden administration is playing politics with people's lives," said Congresswoman Harshbarger. "The TREAT Act will rightly undo the Biden administration's COVID-19 treatment rationing scheme by federal bureaucrats, and make sure Tennesseans and folks in other states have sufficient access to these effective and life-saving treatments.

"I've heard from doctors and patients in East Tennessee about reports of shortages since this new federal take-over started in early September. These shortages result in delays getting these drugs to providers and patients. These COVID-19 treatments save lives and keep them out of hospitals. We need to put a stop to HHS' rationing system that contradicts health needs across the country. Whoever needs a treatment, I'm committed to working tirelessly with Tennessee officials and my congressional colleagues to get treatments to those who need them."

Monoclonal antibodies (mAbs) are laboratory-made proteins that stimulate the immune system so someone can fight off a COVID-19 infection. The goal of this therapy is to help prevent hospitalizations, reduce viral loads, and lessen symptom severity. Monoclonal antibody treatments can be given by a shot or an IV infusion.

Source